Cargando…

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma

SLC17A9 is a vesicular ATP transport protein that plays an important role in determining cell functions and the onset and progression of different diseases. In this study, SLC17A9 was initially identified as a potential diagnostic and prognostic risk biomarker for clear cell renal cell carcinoma (cc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Weiquan, Xu, Ning, Meng, Xiangui, Yuan, Hongwei, Yu, Tiexi, Miao, Qi, Yang, Hongmei, Hai, Bo, Xiao, Wen, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800294/ https://www.ncbi.nlm.nih.gov/pubmed/36590170 http://dx.doi.org/10.1016/j.isci.2022.105764

Ejemplares similares

Up-regulation of SLC27A2 suppresses the proliferation and invasion of renal cancer by down-regulating CDK3-mediated EMT
por: Xu, Ning, et al.
Publicado: (2022)

TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress
por: Yuan, Hongwei, et al.
Publicado: (2023)

PTHLH Predicts the Prognosis of Patients with Oral Leukoplakia
por: Lv, Zhongjing, et al.
Publicado: (2020)

KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion
por: Meng, Xiangui, et al.
Publicado: (2022)

Downregulation of RNA binding protein 47 predicts low survival in patients and promotes the development of renal cell malignancies through RNA stability modification
por: Wang, Cheng, et al.
Publicado: (2023)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

The Expression of PTHLH in Human Gastric Mucosa Enterochromaffin-Like Cells
por: Liu, Cuiping, et al.
Publicado: (2010)

Pthlh, a promising cancer modifier gene in rat tongue carcinogenesis
por: SUWA, HIROHIKO, et al.
Publicado: (2014)

Novel Pathogenetic Variants in PTHLH and TRPS1 Genes Causing Syndromic Brachydactyly
por: Elli, Francesca Marta, et al.
Publicado: (2022)

Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma
por: Meng, Xiangui, et al.
Publicado: (2021)

A Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC
por: Li, Weiquan, et al.
Publicado: (2022)

The Role of PTHLH in Ovarian Follicle Selection, Its Transcriptional Regulation and Genetic Effects on Egg Laying Traits in Hens
por: Guo, Xiaoli, et al.
Publicado: (2019)

Novel Mutation in PTHLH Related to Brachydactyly Type E2 Initially Confused with Unclassical Pseudopseudohypoparathyroidism
por: Bae, Jihong, et al.
Publicado: (2018)

Intrinsic electrophysiological properties predict variability in morphology and connectivity among striatal Parvalbumin-expressing Pthlh-cells
por: Bengtsson Gonzales, Carolina, et al.
Publicado: (2020)

Downregulation of microRNA-29b by DNMT3B decelerates chondrocyte apoptosis and the progression of osteoarthritis via PTHLH/CDK4/RUNX2 axis
por: Dou, Pengcheng, et al.
Publicado: (2020)

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Xuegang, et al.
Publicado: (2023)

The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC
por: Tong, Junwei, et al.
Publicado: (2021)

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma
por: Li, Junqing, et al.
Publicado: (2023)

Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report
por: Echaubard, Stéphane, et al.
Publicado: (2022)

A novel mutation in PTHLH in a family with a variable phenotype with brachydactyly, short stature, oligodontia and developmental delay
por: Scheffer-Rath, Mirjam E.A., et al.
Publicado: (2023)

Expression of SLC17A9 in hepatocellular carcinoma and its clinical significance
por: Wu, Jingdong, et al.
Publicado: (2020)

Chondrodysplasia, enchondromas and a chest deformity causing severe pulmonary morbidity in a boy with a PTHLH duplication: A case report
por: Tacke, Carline E., et al.
Publicado: (2021)

Knockdown of SOX9 Inhibits the Proliferation, Invasion, and EMT in Thyroid Cancer Cells
por: Huang, Jie, et al.
Publicado: (2017)

AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma
por: Zhang, Jiakang, et al.
Publicado: (2022)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

Activated PTHLH Coupling Feedback Phosphoinositide to G-Protein Receptor Signal-Induced Cell Adhesion Network in Human Hepatocellular Carcinoma by Systems-Theoretic Analysis
por: Wang, Lin, et al.
Publicado: (2012)

VNUT/SLC17A9, a vesicular nucleotide transporter, regulates osteoblast differentiation
por: Inoue, Asako, et al.
Publicado: (2020)

KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis
por: Chen, Jing, et al.
Publicado: (2022)

Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer
por: Wu, Ning, et al.
Publicado: (2022)

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress
por: Shi, Jian, et al.
Publicado: (2021)

MiRNA-20b/SUFU/Wnt axis accelerates gastric cancer cell proliferation, migration and EMT
por: Peng, Yin, et al.
Publicado: (2021)

CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9
por: Ying, Min, et al.
Publicado: (2023)

SLC12A8 plays a key role in bladder cancer progression and EMT
por: Li, Shun-Lai, et al.
Publicado: (2020)

Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma
por: Chai, Fangyu, et al.
Publicado: (2023)

Lysosomal ATP Transporter SLC17A9 Controls Cell Viability via Regulating Cathepsin D
por: Huang, Peng, et al.
Publicado: (2022)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer
por: Gao, Huabin, et al.
Publicado: (2021)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gf0h7te3a1h2587tt2pdq47p92